This Article Full Text Full Text (PDF) Other Versions of this Article: AAC.00525-06v1 50/12/4030    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Randall, L. P. Articles by Woodward, M. J. Search for Related Content PubMed PubMed Citation Articles by Randall, L. P. Articles by Woodward, M. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2006, p. 4030-4037, Vol. 50, No. 12
0066-4804/06/$08.00+0     doi:10.1128/AAC.00525-06

Modification of Enrofloxacin Treatment Regimens for Poultry Experimentally Infected with Salmonella enterica Serovar Typhimurium DT104 To Minimize Selection of Resistance

Department of Food and Environmental Safety, Veterinary Laboratories Agency, New Haw, Surrey, KT15 3NB, United Kingdom,¹ Antimicrobial Agents Research Group, Division of Immunity and Infection, University of Birmingham, Birmingham, B15 2TT, United Kingdom²

Received 28 April 2006/ Returned for modification 2 July 2006/ Accepted 19 September 2006

We hypothesized that higher doses of fluoroquinolones for a shorter duration could maintain efficacy (as measured by reduction in bacterial count) while reducing selection in chickens of bacteria with reduced susceptibility. Chicks were infected with Salmonella enterica serovar Typhimurium DT104 and treated 1 week later with enrofloxacin at the recommended dose for 5 days (water dose adjusted to give 10 mg/kg of body weight of birds or equivalence, i.e., water at 50 ppm) or at 2.5 or 5 times the recommended dose for 2 days or 1 day, respectively. The dose was delivered continuously (ppm) or pulsed in the water (mg/kg) or by gavage (mg/kg). In vitro in sera, increasing concentrations of 0.5 to 8 µg/ml enrofloxacin correlated with increased activity. In vivo, the efficacy of the 1-day treatment was significantly less than that of the 2- and 5-day treatments. The 2-day treatments showed efficacy similar to that of the 5-day treatment in all but one repeat treatment group and significantly (P < 0.01) reduced the Salmonella counts. Dosing at 2.5x the recommended dose and pulsed dosing both increased the peak antibiotic concentrations in cecal contents, liver, lung, and sera as determined by high-pressure liquid chromatography. There was limited evidence that shorter treatment regimens (in particular the 1-day regimen) selected for fewer strains with reduced susceptibility. In conclusion, the 2-day treatment would overall require a shorter withholding time than the 5-day treatment and, in view of the increased peak antibiotic concentrations, may give rise to improved efficacy, in particular for treating respiratory and systemic infections. However, it would be necessary to validate the 2-day regimen in a field situation and in particular against respiratory and systemic infections to validate or refute this hypothesis.

Published ahead of print on 9 October 2006.

This article has been cited by other articles:

• Randall, L. P., Bagnall, M. C., Karatzas, K. A., Coldham, N. C., Piddock, L. J. V., Woodward, M. J. (2008). Fitness and dissemination of disinfectant-selected multiple-antibiotic-resistant (MAR) strains of Salmonella enterica serovar Typhimurium in chickens. J Antimicrob Chemother 61: 156-162 [Abstract] [Full Text]